by Vora Corporate Finance | Jan 4, 2025 | Insights, Private Equity & IPO
Transaction: EPACK Prefab secured USD 20 million in the first funding round, led by GEF Capital Partners, global private equity fund. This funding underscores EPACK Prefab’s commitment to sustainability, leveraging modular construction technologies with a...
by Vora Corporate Finance | Jan 4, 2025 | Insights
There were 15 main board IPOs in December 2024 of Suraksha Diagnostics Limited, as One Mobikwik Systems Limited, Sai Life Sciences Limited, Vishal Mega Mart Limited, Inventurus Knowledge Solutions LIMITED, International Gemmolgical Institue India Limited, Transrail...
by Vora Corporate Finance | Dec 30, 2024 | Insights
The International Monetary Fund (IMF) upgraded India’s GDP projections by 20 basis points to 7 percent, from previous estimate of 6.8 percent in April, reflecting carryover from upward revisions to growth in 2023 and improved prospects for private consumption,...
by Vora Corporate Finance | Dec 20, 2024 | Insights, Merger & Acquisitions
Transaction: Metropolis Healthcare Limited, India’s second-largest pathology chain acquires 100% stake in oncology-focused diagnostic services provider Core Diagnostics for Rs 246.8 Crore. The acquisition will take place through a combination of cash and stock, with...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
